reboxetine has been researched along with thiophenes in 7 studies
Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (thiophenes) | Trials (thiophenes) | Recent Studies (post-2010) (thiophenes) |
---|---|---|---|---|---|
626 | 193 | 184 | 17,012 | 1,961 | 8,038 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Preskorn, SH | 1 |
Almási, J; Rihmer, Z | 1 |
Alamo, C; Camarasa, X; García-García, P; López-Muñoz, F; Pardo, A; Seguí, J | 1 |
Bellodi, L; Calati, R; Chiesa, A; De Ronchi, D; Perna, G; Serretti, A | 1 |
Chapman, A; Delivuk, M; Gartlehner, G; Gaynes, BN; Kaminski, A; Thaler, K | 1 |
Hysek, CM; Liechti, ME | 1 |
Chapman, A; Gartlehner, G; Gaynes, BN; Nussbaumer-Streit, B; Probst, T; Sönnichsen, A; Thaler, K; Winkler, D | 1 |
6 review(s) available for reboxetine and thiophenes
Article | Year |
---|---|
Reboxetine: a norepinephrine selective reuptake pump inhibitor.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Biological Availability; Clinical Trials as Topic; Cyclopropanes; Depressive Disorder, Major; Drug Approval; Duloxetine Hydrochloride; Humans; Metabolic Clearance Rate; Milnacipran; Morpholines; Reboxetine; Thiazepines; Thiophenes; United States | 2004 |
[Review of antidepressants from the TCAs to the third generation drugs].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Cyclohexanols; Cyclopropanes; Depressive Disorder, Major; Drug Combinations; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Morpholines; Piperazines; Pyrimidines; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Trazodone; Triazoles; Venlafaxine Hydrochloride | 2004 |
Novel antidepressants and panic disorder: evidence beyond current guidelines.
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Morpholines; Panic Disorder; Practice Guidelines as Topic; Reboxetine; Thiophenes | 2011 |
Second-generation antidepressants for seasonal affective disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Phototherapy; Randomized Controlled Trials as Topic; Reboxetine; Seasonal Affective Disorder; Thiophenes | 2011 |
Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex.
Topics: Adrenergic Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Adult; Affect; Autonomic Agents; Body Temperature Regulation; Carbazoles; Carvedilol; Clonidine; Cross-Over Studies; Dopamine Uptake Inhibitors; Doxazosin; Duloxetine Hydrochloride; Female; Hemodynamics; Humans; Light; Male; Miosis; Morpholines; Mydriasis; Mydriatics; N-Methyl-3,4-methylenedioxyamphetamine; Propanolamines; Randomized Controlled Trials as Topic; Reaction Time; Reboxetine; Recovery of Function; Reflex, Pupillary; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Young Adult | 2012 |
Second-generation antidepressants for treatment of seasonal affective disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Bias; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Morpholines; Observational Studies as Topic; Phototherapy; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Reboxetine; Seasonal Affective Disorder; Thiophenes; Treatment Outcome | 2021 |
1 trial(s) available for reboxetine and thiophenes
Article | Year |
---|---|
Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Drug Resistance; Drug Therapy, Combination; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2010 |